Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
Dow
Moodys
Mallinckrodt

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,028,439

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,028,439
Title: Inhibition of parathyroid hormone secretion
Abstract:Parathyroid Hormone, when excessively synthesized, induces pathologic bone resorption and demineralization and results in hypocalcemia which produces toxic effects in soft tissues. Non-toxic water-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid, administered orally or systemically, inhibits parathyroid hormone induced bone resorption in vitro and in vivo in warm blooded animals.
Inventor(s): Gaffar; Abdul (Somerset, NJ)
Assignee: Colgate Palmolive Company (Piscataway, NJ)
Application Number:07/296,390
Patent Claims:1. A method for inhibiting parathyroid hormone induced bone resorption which comprises administering to a warm blooded mammal host having oversecretion of parathyroid hormone a daily dosage of about 0.1-6 grams per kilogram body weight when said administration is oral, or about 0.1-2 grams per kilogram body weight when said administration is systemic, of a non-toxic water soluble pharmaceutically acceptable potassium salt of peroxydiphosphate.

2. The method claimed in claim 1 wherein said peroxydiphosphate compound is present in amount of about 0.1-7% in a pharmaceutical carrier.

3. The method claimed in claim 2 wherein said peroxydiphosphate compound is present in tabletted granules having a coating thereon which is not broken down during passage through the stomach of said warm blooded animal and which coating is dissolved by intestinal fluids having a pH of 5-10.

4. The method claimed in claim 2 wherein said peroxydiphosphate compound is administered to said warm blooded animal in a solution of non-pyrogenic distilled water and sodium chloride buffered with phosphate.

Details for Patent 5,028,439

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Colgate Palmolive Company (Piscataway, NJ) 2008-07-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Colgate Palmolive Company (Piscataway, NJ) 2008-07-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Colgate Palmolive Company (Piscataway, NJ) 2008-07-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Colgate Palmolive Company (Piscataway, NJ) 2008-07-02 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Dow
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.